Cancer Health Treatment Update Meeting Your Match: Genomic Testing Genomic testing of tumor tissue or cancer DNA in blood samples can help customize treatment to target tumors. Immunotherapy Plus Targeted Drug Combination Improves Kidney Cancer Survival First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer. What's Next for T-Cell Therapies? After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors. Monoclonal Antibody Therapy Shows Early Promise For Advanced Pancreatic Cancer Experimental monoclonal antibody sotigalimab shows promising results in a Phase I study. Advertisement ‘Cruel’ Digital Race For Vaccines Leaves Many Seniors Behind In most places, elderly people are pitted against one another, competing on an unstable technological playing field for limited shots. Long-Haul COVID Cases Cast New Light on Chronic Fatigue Sufferers Chronic fatigue syndrome is a complicated disorder characterized by extreme fatigue that lasts for at least six months.  More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Winter 2021 Check out our latest print edition! Newsfeed UPDATED: Rush Limbaugh Has Died From Lung Cancer American Cancer Society's New Diversity in Cancer Research Program Will You Be Able to Keep Your Job Post-Cancer? Strategies to Improve Cancer-Related Fatigue Symptoms Blog: Food and Drug Administration (FDA) FDA Approves Ukoniq for Marginal Zone and Follicular Lymphoma FDA Approves Opdivo Plus Cabometyx for Advanced Kidney Cancer FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer Newsfeed UPDATED: Rush Limbaugh Has Died From Lung Cancer American Cancer Society's New Diversity in Cancer Research Program Will You Be Able to Keep Your Job Post-Cancer? Strategies to Improve Cancer-Related Fatigue Symptoms Blog: Food and Drug Administration (FDA) FDA Approves Ukoniq for Marginal Zone and Follicular Lymphoma FDA Approves Opdivo Plus Cabometyx for Advanced Kidney Cancer FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: